Phase 1 Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older.
- People with a good general health and activity level, rated 0 or 1 on the WHO performance scale (meaning fully active or able to carry out light work).
- People with a mouth opening of at least 40mm (for women) or 45mm (for men) before treatment begins.
- People who have been diagnosed with squamous cell carcinoma (a type of cancer) in the mouth, throat, or voice box, confirmed by a tissue or cell sample.
- People whose cancer is at an advanced local stage (stage III or IV).
- People whose treatment plan involves radiotherapy as the main treatment, where standard additional drug-based treatment is not suitable for them.
- People who are able to understand what the study involves and are willing and able to sign a written consent form, as assessed by their treating doctor.
Who may not be able to join:
- People who have previously had radiation treatment to the same area being targeted in this trial.
- People who have a condition or situation that may make it difficult to attend follow-up appointments as required.
- People who have a pacemaker, or who have clustered metal markers in their body where the total length of metal in direct contact exceeds 2cm.
- People whose tumour is located below a tracheostomy (a surgical opening in the neck), as this may prevent the treatment from reaching the tumour.
- People whose shoulder anatomy would prevent the treatment device from being properly positioned.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michiel Kroesen, MD, Dr., Erasmus Medical Center
Phone: +31107041116
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Dose Limiting Toxicity of Thermotherapy; Feasibility of Thermotherapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.